Treatment-resistant Depress
Successful management of patients with treatment-resistant depression requires a thorough understanding of the biological basis for both the depression and its failure to respond to standard treatments. This book clearly and succinctly summarizes the latest scientific research and its applications in clinical practice.
A first step is a clear definition of what constitutes treatment-resistant depression so that clinical trials and other studies are using common criteria, enabling comparison and meta-analysis of their outcomes. The opening chapter reviews definitions and predictors of treatment-resistant depression originating from different fields and discusses their usefulness in clinical practice and clinical research. The next chapter proposes a new definition, adapting terminology from medicine.
Biological classification requires identification of genetic risk factors and gene variants have been identified as accounting for 50% of the variance in the clinical outcomes of antidepressant treatments. Chapter 3 describes several genes already associated with treatment-resistant depression and, while further work is needed to translate findings into clinical recommendations, suggests that genetic prediction of treatment resistance could become a widespread clinical reality within a few years.
Most patients with treatment-resistant depression will be treated pharmacologically, so three chapters review the latest evidence for pharmacological best practice in switching strategies for antidepressants, the role of antipsychotics and augmentation strategies to complement lithium.
There are two major alternatives to pharmacotherapy: neuromodulation and psychotherapy. The brain intervention chapter summarizes clinical research and experience with electroconvulsive therapy, transcranial magnetic stimulation, vagus nerve stimulation, deep brain stimulation and magnetic seizure therapy. The final chapter reviews the literature pertaining to the effectiveness of various forms of psychotherapy in patients who have not responded to antidepressant pharmacotherapy, explaining that patients who have not responded to one or two trials of antidepressant medication have a 30%-50% chance of responding to a focused psychotherapy. It proposes indications for psychotherapy in treatment-resistant depression and summarizes general therapeutic principles.
Essential reading for all psychiatrists managing patients with this distressing disorder.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Professor Dr Kasper is Professor of Psychiatry and Chairman of the Department of General Psychiatry at the Medical University of Vienna, Austria. He is Honorary Professor at the University of Hong Kong, China. He concentrates on the biological bases of mental disorders and their possible treatment approaches. He has conducted studies in psychopathological as well as clinical areas. Dr Kasper is a frequent national and international speaker and is actively involved in research programmes studying depression, anxiety, psychosis, and dementia, authoring over 800 research reports and reviews. Dr Kasper serves on the editorial boards of numerous learned journals, including European Archives of Psychiatry and Neuroscience, European Psychiatry, and European Neuropsychopharmacology. He is Co-editor in-chief of the International Journal of Psychiatry in Clinical Practice.
Professor Montgomery was Professor of Psychiatry at Imperial College, University of London until his retirement in 1996 when he became Emeritus Professor of Psychiatry. He has great breadth of experience in the field of psychotropic medicine with seminal work in depression, anxiety disorders, suicide prevention and schizophrenia. He has published 26 books and more than 400 papers. Professor Montgomery is editor of International Clinical Psychopharmacology and was editor of European Neuropsychopharmacology for 20 years. He also serves on the editorial board of numerous scientific journals.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Unique Books, Lexington, KY, Etats-Unis
Soft cover. Etat : Near Fine. No Jacket. 1st Edition. b-362 Some highlighting. N° de réf. du vendeur b-363-11
Quantité disponible : 1 disponible(s)
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 12445254-n
Quantité disponible : Plus de 20 disponibles
Vendeur : Books Puddle, New York, NY, Etats-Unis
Etat : New. pp. viii + 217 Index. N° de réf. du vendeur 2650447646
Quantité disponible : 4 disponible(s)
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Paperback. Etat : new. Paperback. Treatment-resistant Depress Successful management of patients with treatment-resistant depression requires a thorough understanding of the biological basis for both the depression and its failure to respond to standard treatments. This book clearly and succinctly summarizes the latest scientific research and its applications in clinical practice. A first step is a clear definition of what constitutes treatment-resistant depression so that clinical trials and other studies are using common criteria, enabling comparison and meta-analysis of their outcomes. The opening chapter reviews definitions and predictors of treatment-resistant depression originating from different fields and discusses their usefulness in clinical practice and clinical research. The next chapter proposes a new definition, adapting terminology from medicine. Biological classification requires identification of genetic risk factors and gene variants have been identified as accounting for 50% of the variance in the clinical outcomes of antidepressant treatments. Chapter 3 describes several genes already associated with treatment-resistant depression and, while further work is needed to translate findings into clinical recommendations, suggests that genetic prediction of treatment resistance could become a widespread clinical reality within a few years. Most patients with treatment-resistant depression will be treated pharmacologically, so three chapters review the latest evidence for pharmacological best practice in switching strategies for antidepressants, the role of antipsychotics and augmentation strategies to complement lithium. There are two major alternatives to pharmacotherapy: neuromodulation and psychotherapy. The brain intervention chapter summarizes clinical research and experience with electroconvulsive therapy, transcranial magnetic stimulation, vagus nerve stimulation, deep brain stimulation and magnetic seizure therapy. The final chapter reviews the literature pertaining to the effectiveness of various forms of psychotherapy in patients who have not responded to antidepressant pharmacotherapy, explaining that patients who have not responded to one or two trials of antidepressant medication have a 30%-50% chance of responding to a focused psychotherapy. It proposes indications for psychotherapy in treatment-resistant depression and summarizes general therapeutic principles. Essential reading for all psychiatrists managing patients with this distressing disorder. The first book devoted to a challenging disorder that affects millions of people around the world. Essential reading for all psychiatrists who manage these patients. . Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9781119952909
Quantité disponible : 1 disponible(s)
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 12445254
Quantité disponible : Plus de 20 disponibles
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. pp. viii + 217 Illus. N° de réf. du vendeur 58096321
Quantité disponible : 4 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. pp. viii + 217. N° de réf. du vendeur 1850447636
Quantité disponible : 4 disponible(s)
Vendeur : Romtrade Corp., STERLING HEIGHTS, MI, Etats-Unis
Etat : New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. N° de réf. du vendeur ABBB-51518
Quantité disponible : 2 disponible(s)
Vendeur : Basi6 International, Irving, TX, Etats-Unis
Etat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. N° de réf. du vendeur ABEOCT25-145480
Quantité disponible : 3 disponible(s)
Vendeur : SMASS Sellers, IRVING, TX, Etats-Unis
Etat : New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed. N° de réf. du vendeur ASNNN-51518
Quantité disponible : 1 disponible(s)